Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Indexes aggregate market data to track performance, provide benchmarks, and simplify investment decisions for portfolios and strategies.
23,857 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Investors are rethinking income strategies as inflation pressures linger and long-term payout growth demonstrates gre...
Jim Cramer argues that the MAG 7 must be analyzed separately, not as a single basket, outlining five core reasons eac...
Taiwan Semiconductor's Q2 report is due July 16, shaping AI capex bets. Five stocks stand out as potential winners or...
Meta Platforms expands its lead in scalable ads and AI infrastructure, widening the gap to Palantir, whose high multi...
Warren Buffett is terminating his storied partnership with the Gates Foundation, directing billions to family-led fou...
A Palestinian activist has filed a federal lawsuit accusing a network of conservative groups of coordinating to silen...
Two dividend ETFs quietly beating SCHD on total return since early 2022 have captured investor interest as market con...
Publicly traded crypto firms rose 23% in the first half of 2026 while crypto assets declined 36%, widening the gap to...
A 70-year-old inherits $100,000 with almost nothing saved and converts it into guaranteed lifetime income with a sing...
Rocket Lab shares hover near $67 as July odds tilt toward downside. This story breaks down what prediction markets be...
Tesla is signaling stronger profit margins and robust cash flow, setting up a potential 12% rally in the coming year....